The goal of this clinical trial is to learn if adding cancer-specific amplitude-modulated radiofrequency electromagnetic field therapy (TheraBionic P1 device) …

Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIA+2 more

~Estimated

~$10 – $7,500

Barbara Ann Karmanos Cancer InstituteNCT07218432

Phase 1

A Phase 1/2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of INX-315 in Patients With Advanced Cancer

Incyclix Bio (Incyclix) is developing INX-315 as an oral, small molecule inhibitor of cyclin dependent kinase 2 (CDK2) for the treatment of human cancers. This…

Breast CancerBreast Cancer MetastaticHormone Receptor Positive Tumor+6 more

~Estimated

~$10 – $8,750

Incyclix BioNCT05735080

Phase 4

Evaluation of Revaree Plus in Women With Breast Cancer

The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness du…

Breast CancerStage 0 Breast CancerStage I Breast Cancer+8 more

~Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07042581

← PreviousPage 3 of 3Next →